Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected Patients
Status:
Completed
Trial end date:
2016-11-23
Target enrollment:
Participant gender:
Summary
This study aims to provide information about the safety and pharmacokinetic drug-drug
interactions between darunavir/cobicistat (800/150mg QD) and etravirine (400mg QD) in
HIV-infected patients, as well as evaluate the efficacy of concomitant administration of
darunavir/cobicistat and etravirine.
Phase:
Phase 1
Details
Lead Sponsor:
Fundacio Lluita Contra la SIDA Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia